VPS37D
gene geneOn this page
Also known as MGC35352
Summary
VPS37D (VPS37D subunit of ESCRT-I, HGNC:18287) is a protein-coding gene on chromosome 7q11.23, encoding Vacuolar protein sorting-associated protein 37D (Q86XT2). Component of the ESCRT-I complex, a regulator of vesicular trafficking process.
Predicted to be involved in protein targeting to membrane; protein targeting to vacuole; and ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway. Located in extracellular exosome. Part of ESCRT I complex.
Source: NCBI Gene 155382 — RefSeq curated summary.
At a glance
- GWAS associations: 8
- Clinical variants (ClinVar): 64 total
- Phenotypes (HPO): 186
- MANE Select transcript:
NM_001077621
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18287 |
| Approved symbol | VPS37D |
| Name | VPS37D subunit of ESCRT-I |
| Location | 7q11.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC35352 |
| Ensembl gene | ENSG00000176428 |
| Ensembl biotype | protein_coding |
| OMIM | 610039 |
| Entrez | 155382 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 protein_coding
ENST00000324941, ENST00000451519, ENST00000903466, ENST00000965880
RefSeq mRNA: 1 — MANE Select: NM_001077621
NM_001077621
CCDS: CCDS43596
Canonical transcript exons
ENST00000324941 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001228064 | 73669419 | 73669590 |
| ENSE00001228075 | 73670020 | 73670102 |
| ENSE00001228086 | 73667831 | 73668096 |
| ENSE00001333472 | 73671014 | 73672110 |
Expression profiles
Bgee: expression breadth ubiquitous, 180 present calls, max score 89.90.
FANTOM5 (CAGE): breadth broad, TPM avg 0.5531 / max 7.8349, expressed in 330 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 79011 | 0.5531 | 330 |
Top tissues by expression
237 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| pancreatic ductal cell | CL:0002079 | 89.90 | silver quality |
| cortical plate | UBERON:0005343 | 86.58 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 85.95 | gold quality |
| ganglionic eminence | UBERON:0004023 | 85.94 | gold quality |
| kidney epithelium | UBERON:0004819 | 85.84 | gold quality |
| upper arm skin | UBERON:0004263 | 83.84 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 83.18 | gold quality |
| cerebellar vermis | UBERON:0004720 | 83.11 | silver quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 81.57 | gold quality |
| ventricular zone | UBERON:0003053 | 80.69 | gold quality |
| endothelial cell | CL:0000115 | 80.14 | silver quality |
| vena cava | UBERON:0004087 | 80.02 | gold quality |
| ventral tegmental area | UBERON:0002691 | 79.89 | silver quality |
| renal medulla | UBERON:0000362 | 79.71 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.62 | gold quality |
| prefrontal cortex | UBERON:0000451 | 79.61 | gold quality |
| pericardium | UBERON:0002407 | 79.45 | silver quality |
| anterior cingulate cortex | UBERON:0009835 | 78.85 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 78.71 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 78.66 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 78.56 | silver quality |
| substantia nigra pars compacta | UBERON:0001965 | 78.29 | silver quality |
| neocortex | UBERON:0001950 | 78.11 | gold quality |
| frontal cortex | UBERON:0001870 | 77.91 | gold quality |
| nucleus accumbens | UBERON:0001882 | 77.91 | gold quality |
| cortex of kidney | UBERON:0001225 | 77.62 | gold quality |
| right frontal lobe | UBERON:0002810 | 77.58 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 77.41 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 77.34 | gold quality |
| heart right ventricle | UBERON:0002080 | 77.33 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.60 |
Regulation
Is transcription factor: no
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | vps37d | ENSDARG00000097055 |
| mus_musculus | Vps37d | ENSMUSG00000043614 |
| rattus_norvegicus | Vps37d | ENSRNOG00000048699 |
| drosophila_melanogaster | Vps37B | FBGN0037299 |
Paralogs (3): VPS37B (ENSG00000139722), VPS37A (ENSG00000155975), VPS37C (ENSG00000167987)
Protein
Protein identifiers
Vacuolar protein sorting-associated protein 37D — Q86XT2 (reviewed: Q86XT2)
Alternative names: ESCRT-I complex subunit VPS37D, Williams-Beuren syndrome chromosomal region 24 protein
All UniProt accessions (2): Q86XT2, C9JYT9
UniProt curated annotations — full annotation on UniProt →
Function. Component of the ESCRT-I complex, a regulator of vesicular trafficking process. Required for the sorting of endocytic ubiquitinated cargos into multivesicular bodies. May be involved in cell growth and differentiation.
Subunit / interactions. Component of the ESCRT-I complex (endosomal sorting complex required for transport I) which consists of TSG101, VPS28, a VPS37 protein (VPS37A to -D) and MVB12A or MVB12B in a 1:1:1:1 stoichiometry. Interacts with TSG101 and MVB12A. Component of the ESCRT-I complex (endosomal sorting complex required for transport I) which consists of TSG101, VPS28, a VPS37 protein (VPS37A to -D) and UBAP1 in a 1:1:1:1 stoichiometry.
Subcellular location. Late endosome membrane.
Disease relevance. VPS37D is located in the Williams-Beuren syndrome (WBS) critical region. WBS results from a hemizygous deletion of several genes on chromosome 7q11.23, thought to arise as a consequence of unequal crossing over between highly homologous low-copy repeat sequences flanking the deleted region.
Similarity. Belongs to the VPS37 family.
RefSeq proteins (1): NP_001071089* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR009851 | Mod_r | Domain |
Pfam: PF07200
UniProt features (4 total): chain 1, domain 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q86XT2-F1 | 81.37 | 0.61 |
Function
Pathways and Gene Ontology
Reactome pathways
5 pathways
| ID | Pathway |
|---|---|
| R-HSA-162588 | Budding and maturation of HIV virion |
| R-HSA-174490 | Membrane binding and targetting of GAG proteins |
| R-HSA-917729 | Endosomal Sorting Complex Required For Transport (ESCRT) |
| R-HSA-9610379 | HCMV Late Events |
| R-HSA-9615710 | Late endosomal microautophagy |
MSigDB gene sets: 545 (showing top):
GSE45365_NK_CELL_VS_BCELL_DN, REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT, GOBP_ENDOSOME_ORGANIZATION, GOBP_INTRACELLULAR_PROTEIN_TRANSPORT, BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN, GOBP_VESICLE_ORGANIZATION, GOBP_PROTEIN_TARGETING, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, GOBP_VACUOLAR_TRANSPORT, GOBP_VESICLE_MEDIATED_TRANSPORT, REACTOME_MEMBRANE_TRAFFICKING, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOBP_MACROAUTOPHAGY, GOBP_PROTEIN_TARGETING_TO_MEMBRANE, REACTOME_HIV_INFECTION
GO Biological Process (9): protein targeting to membrane (GO:0006612), protein targeting to vacuole (GO:0006623), macroautophagy (GO:0016236), multivesicular body assembly (GO:0036258), viral budding via host ESCRT complex (GO:0039702), ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162), protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328), membrane fission (GO:0090148), protein transport (GO:0015031)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (6): ESCRT I complex (GO:0000813), endosome membrane (GO:0010008), late endosome membrane (GO:0031902), extracellular exosome (GO:0070062), endosome (GO:0005768), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-5 pathways:
| Category | Pathways |
|---|---|
| Late Phase of HIV Life Cycle | 1 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | 1 |
| Membrane Trafficking | 1 |
| HCMV Infection | 1 |
| Autophagy | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein targeting | 2 |
| intracellular protein transport | 2 |
| protein localization to vacuole | 2 |
| establishment of protein localization to vacuole | 2 |
| endosome membrane | 2 |
| establishment of protein localization to membrane | 1 |
| vacuolar transport | 1 |
| autophagosome assembly | 1 |
| autophagy | 1 |
| multivesicular body organization | 1 |
| organelle assembly | 1 |
| viral budding | 1 |
| ubiquitin-dependent protein catabolic process | 1 |
| protein catabolic process in the vacuole | 1 |
| multivesicular body sorting pathway | 1 |
| late endosome to vacuole transport via multivesicular body sorting pathway | 1 |
| ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 1 |
| membrane organization | 1 |
| transport | 1 |
| intracellular protein localization | 1 |
| establishment of protein localization | 1 |
| binding | 1 |
| ESCRT complex | 1 |
| membrane protein complex | 1 |
| endosome | 1 |
| cytoplasmic vesicle membrane | 1 |
| bounding membrane of organelle | 1 |
| late endosome | 1 |
| extracellular vesicle | 1 |
| endomembrane system | 1 |
| cytoplasmic vesicle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
477 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| VPS37D | VPS28 | Q9UK41 | 795 |
| VPS37D | TSG101 | Q99816 | 658 |
| VPS37D | MVB12A | Q96EY5 | 652 |
| VPS37D | MVB12B | Q9H7P6 | 592 |
| VPS37D | UBAP1 | Q9NZ09 | 583 |
| VPS37D | VPS36 | Q86VN1 | 544 |
| VPS37D | SNF8 | Q96H20 | 462 |
| VPS37D | CHMP3 | Q9Y3E7 | 460 |
| VPS37D | A0A140T963 | A0A140T963 | 460 |
| VPS37D | VPS25 | Q9BRG1 | 455 |
| VPS37D | CHMP4C | Q96CF2 | 444 |
| VPS37D | TMEM270 | Q6UE05 | 426 |
| VPS37D | CHMP2A | O43633 | 416 |
| VPS37D | GTF2IRD1 | Q9UHL9 | 413 |
| VPS37D | OR11L1 | Q8NGX0 | 400 |
IntAct
18 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| VPS37D | ARMC7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| VPS37D | CRTAP | psi-mi:“MI:0914”(association) | 0.530 |
| CEP55 | VPS37D | psi-mi:“MI:0915”(physical association) | 0.370 |
| TRAF2 | UMAD1 | psi-mi:“MI:0914”(association) | 0.350 |
| RBCK1 | UMAD1 | psi-mi:“MI:0914”(association) | 0.350 |
| SHARPIN | MAP3K7 | psi-mi:“MI:0914”(association) | 0.350 |
| VPS28 | DCAF6 | psi-mi:“MI:0914”(association) | 0.350 |
| VPS28 | PRPF6 | psi-mi:“MI:0914”(association) | 0.350 |
| VPS37D | RPSA2 | psi-mi:“MI:0914”(association) | 0.350 |
| CACYBP | VPS37C | psi-mi:“MI:0914”(association) | 0.350 |
| CAPRIN1 | SDCBP | psi-mi:“MI:0914”(association) | 0.350 |
| EIF4A1 | SNAP23 | psi-mi:“MI:0914”(association) | 0.350 |
| CSDE1 | VPS37C | psi-mi:“MI:0914”(association) | 0.350 |
| ARMC7 | VPS37D | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (26): VPS37D (Affinity Capture-MS), ACAD8 (Affinity Capture-MS), TSG101 (Affinity Capture-MS), CRTAP (Affinity Capture-MS), SAV1 (Affinity Capture-MS), P3H1 (Affinity Capture-MS), AASS (Affinity Capture-MS), KIAA1279 (Affinity Capture-MS), VPS37D (Affinity Capture-MS), VPS37D (Affinity Capture-MS), VPS37D (Affinity Capture-MS), VPS37D (Affinity Capture-MS), VPS37D (Two-hybrid), P3H1 (Affinity Capture-MS), CRTAP (Affinity Capture-MS)
ESM2 similar proteins: A0A8I5KY20, A2A9T0, A2IDD5, B0BNK9, B8ZZ34, C9JI98, C9JLR9, F5GYI3, O18734, P0CG25, P84157, Q0IIA6, Q0PHV7, Q0X0E2, Q13387, Q1RMK9, Q2M3D2, Q2TAM9, Q3ZCQ3, Q4VA45, Q673H1, Q69YZ2, Q6NS60, Q6P6N5, Q6PJ61, Q7Z6J2, Q80ZJ8, Q810I0, Q86SX3, Q86UD0, Q86XT2, Q8BNN1, Q8IUW3, Q8N4Y2, Q8N6N2, Q8QZV0, Q8R4T5, Q8TF61, Q8VCR9, Q8WXF8
Diamond homologs: A5D8V6, Q5R9T2, Q810I0, Q86XT2, Q8R0J7, Q8R105, Q9H9H4, Q9SCP9, Q8NEZ2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
64 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 53 |
| Likely benign | 6 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
749 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:73668092:GGAAG:G | donor_gain | 1.0000 |
| 7:73668093:G:GT | donor_gain | 1.0000 |
| 7:73668094:A:T | donor_gain | 1.0000 |
| 7:73669415:GCA:G | acceptor_loss | 1.0000 |
| 7:73669417:A:AG | acceptor_gain | 1.0000 |
| 7:73669418:G:GA | acceptor_gain | 1.0000 |
| 7:73669418:GT:G | acceptor_gain | 1.0000 |
| 7:73669418:GTT:G | acceptor_gain | 1.0000 |
| 7:73669418:GTTCC:G | acceptor_gain | 1.0000 |
| 7:73669555:TGGCC:T | donor_gain | 1.0000 |
| 7:73669556:GGCCG:G | donor_gain | 1.0000 |
| 7:73669589:GG:G | donor_gain | 1.0000 |
| 7:73669590:GG:G | donor_gain | 1.0000 |
| 7:73669591:G:GG | donor_gain | 1.0000 |
| 7:73669591:GTGA:G | donor_loss | 1.0000 |
| 7:73671006:C:A | acceptor_gain | 1.0000 |
| 7:73668055:G:GT | donor_gain | 0.9900 |
| 7:73668096:GGTAG:G | donor_loss | 0.9900 |
| 7:73668097:GTA:G | donor_loss | 0.9900 |
| 7:73668098:T:A | donor_loss | 0.9900 |
| 7:73669418:GTTC:G | acceptor_gain | 0.9900 |
| 7:73669598:C:T | donor_gain | 0.9900 |
| 7:73669905:GAAAC:G | donor_gain | 0.9900 |
| 7:73670010:T:TA | acceptor_gain | 0.9900 |
| 7:73671007:G:A | acceptor_gain | 0.9900 |
| 7:73671012:A:AC | acceptor_loss | 0.9900 |
| 7:73671012:A:AG | acceptor_gain | 0.9900 |
| 7:73671013:G:GA | acceptor_gain | 0.9900 |
| 7:73669588:TGG:T | donor_gain | 0.9800 |
| 7:73669589:GGG:G | donor_gain | 0.9800 |
AlphaMissense
1573 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:73668038:T:C | L27P | 0.999 |
| 7:73668047:T:C | L30P | 0.999 |
| 7:73669474:C:A | A65D | 0.999 |
| 7:73669525:T:C | L82P | 0.999 |
| 7:73669546:T:C | L89P | 0.999 |
| 7:73668038:T:A | L27H | 0.998 |
| 7:73669463:C:A | N61K | 0.998 |
| 7:73669463:C:G | N61K | 0.998 |
| 7:73669473:G:C | A65P | 0.998 |
| 7:73669484:C:A | N68K | 0.998 |
| 7:73669484:C:G | N68K | 0.998 |
| 7:73669486:T:C | L69P | 0.998 |
| 7:73671123:T:C | L168P | 0.998 |
| 7:73668050:T:C | L31P | 0.997 |
| 7:73669441:G:C | R54P | 0.997 |
| 7:73671059:T:C | F147L | 0.997 |
| 7:73671061:C:A | F147L | 0.997 |
| 7:73671061:C:G | F147L | 0.997 |
| 7:73669504:T:C | L75P | 0.996 |
| 7:73669527:G:C | A83P | 0.996 |
| 7:73671071:T:C | F151L | 0.996 |
| 7:73671073:C:A | F151L | 0.996 |
| 7:73671073:C:G | F151L | 0.996 |
| 7:73671113:G:C | A165P | 0.996 |
| 7:73668068:T:C | L37P | 0.995 |
| 7:73669482:A:G | N68D | 0.995 |
| 7:73671060:T:C | F147S | 0.995 |
| 7:73671105:G:C | R162P | 0.995 |
| 7:73668088:A:C | S44R | 0.994 |
| 7:73668090:C:A | S44R | 0.994 |
dbSNP variants (sampled 300 via entrez): RS1000079310 (7:73671877 A>G,T), RS1000293803 (7:73666573 C>T), RS1000560888 (7:73672242 C>T), RS1000594615 (7:73667509 G>A), RS1000623786 (7:73668311 C>T), RS1002265169 (7:73669329 C>G,T), RS1002585874 (7:73670336 G>A), RS1002642620 (7:73663411 G>A), RS1002764670 (7:73664692 C>A), RS1002937467 (7:73664487 C>A), RS1004332603 (7:73669035 A>G), RS1004534163 (7:73670306 C>G,T), RS1004601114 (7:73669264 G>A), RS1004672384 (7:73664676 G>A), RS1005073232 (7:73670052 G>A,T)
Disease associations
OMIM: gene MIM:610039 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
186 total (30 of 186 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000010 | Recurrent urinary tract infections |
| HP:0000014 | Abnormality of the bladder |
| HP:0000015 | Bladder diverticulum |
| HP:0000023 | Inguinal hernia |
| HP:0000025 | Functional abnormality of male internal genitalia |
| HP:0000028 | Cryptorchidism |
| HP:0000044 | Hypogonadotropic hypogonadism |
| HP:0000075 | Renal duplication |
| HP:0000076 | Vesicoureteral reflux |
| HP:0000083 | Renal insufficiency |
| HP:0000089 | Renal hypoplasia |
| HP:0000093 | Proteinuria |
| HP:0000121 | Nephrocalcinosis |
| HP:0000125 | Pelvic kidney |
| HP:0000147 | Polycystic ovaries |
| HP:0000154 | Wide mouth |
| HP:0000158 | Macroglossia |
| HP:0000179 | Thick lower lip vermilion |
| HP:0000212 | Gingival overgrowth |
| HP:0000232 | Everted lower lip vermilion |
| HP:0000252 | Microcephaly |
| HP:0000275 | Narrow face |
| HP:0000280 | Coarse facial features |
| HP:0000286 | Epicanthus |
| HP:0000307 | Pointed chin |
| HP:0000337 | Broad forehead |
| HP:0000343 | Long philtrum |
| HP:0000347 | Micrognathia |
| HP:0000348 | High forehead |
| HP:0000358 | Posteriorly rotated ears |
GWAS associations
8 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001905_7 | Hypertriglyceridemia | 2.000000e-06 |
| GCST002650_8 | Coffee consumption (cups per day) | 3.000000e-11 |
| GCST005983_23 | Serum uric acid levels | 4.000000e-09 |
| GCST005988_8 | Serum albumin levels | 2.000000e-09 |
| GCST006019_1 | Gamma glutamyl transferase levels | 1.000000e-21 |
| GCST010725_13 | Malaria | 8.000000e-06 |
| GCST010725_74 | Malaria | 6.000000e-06 |
| GCST010725_91 | Malaria | 7.000000e-06 |
EFO canonical traits (5, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004530 | triglyceride measurement |
| EFO:0004330 | coffee consumption |
| EFO:0006782 | cups of coffee per day measurement |
| EFO:0004761 | uric acid measurement |
| EFO:0004532 | serum gamma-glutamyl transferase measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
24 total (human), top 24 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| trichostatin A | affects cotreatment, decreases expression | 2 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| bisphenol A | increases expression | 1 |
| sodium arsenate | increases abundance, increases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | decreases expression, affects response to substance, increases expression, affects cotreatment | 1 |
| beta-methylcholine | affects expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| nutlin 3 | affects cotreatment, increases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Rosiglitazone | decreases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Temozolomide | decreases expression | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Camptothecin | increases expression | 1 |
| Dactinomycin | affects cotreatment, increases expression | 1 |
| Estradiol | decreases expression | 1 |
| Lipopolysaccharides | increases expression, affects cotreatment, decreases expression, affects response to substance | 1 |
| Niclosamide | increases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Valproic Acid | affects expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.